Gene · 1616
Papers3,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differentiation Versus Grade for Pancreatic Neuroendocrine Neoplasms. | Arch Pathol Lab Med | 2025 | 40031961 | PubTator, text mining | PubMed |
| Should we worry about high-grade pancreatic neuroendocrine tumor progression and alkylating agents?†. | J Pathol | 2025 | 40007046 | PubTator, text mining | PubMed |
| Locking the gates of immortality: targeting alternative lengthening of telomeres (ALT) pathways. | Med Oncol | 2025 | 39964637 | PubTator, text mining | PubMed |
| Challenges of a tailored immunohistochemistry algorithm for uterine leiomyosarcoma: an integrated analysis of leiomyomas with bizarre nuclei and fumarate hydratase (FH) deficiency. | Histopathology | 2025 | 39961604 | PubTator, text mining | PubMed |
| Clinical Relevance of ATRX/DAXX Gene Mutations and ALT in Functioning Pancreatic Neuroendocrine Tumors. | Endocr Pathol | 2025 | 39954168 | PubTator, text mining | PubMed |
| Temporal increase in Ki-67 index in patients with pancreatic neuroendocrine tumours. | Endocr Relat Cancer | 2025 | 39804242 | PubTator, text mining | PubMed |
| ATRX loss inhibits DDR to strengthen radio-sensitization in p53-deficent HCT116 cells. | Sci Rep | 2025 | 39755758 | PubTator, text mining | PubMed |
| CALML3-AS1 enhances malignancies and stemness of small cell lung cancer cells through interacting with DAXX protein and promoting GLUT4-mediated aerobic glycolysis. | Toxicol Appl Pharmacol | 2025 | 39617259 | PubTator, text mining | PubMed |
| Calcium sensing receptor expression is downregulated in gastroenteropancreatic neuroendocrine tumours via epigenetic mechanisms. | Int J Cancer | 2025 | 39579056 | PubTator, text mining | PubMed |
| Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot Study. | Neuroendocrinology | 2025 | 39447548 | PubTator, text mining | PubMed |
| DAXX is associated with early recurrence of pancreatic neuroendocrine tumors after R0 resection. | Surgery | 2025 | 39366850 | PubTator, text mining | PubMed |
| Prognostic and predictive significance of p53 and ATRX in neuroendocrine neoplasms of GIT and pancreas and their utility as an adjunct to accurate diagnosis-An eight-year retrospective study. | Indian J Gastroenterol | 2025 | 39352684 | PubTator, text mining | PubMed |
| Genetic Analysis of Melanoma Types Using Japanese Genomic Database. | Laryngoscope | 2025 | 39119775 | PubTator, text mining | PubMed |
| A cross-species transcriptomic analysis reveals a novel 2-dimensional classification system explaining the invasiveness heterogeneity of pancreatic neuroendocrine tumor. | Cancer Lett | 2025 | 39048044 | PubTator, text mining | PubMed |
| Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine Leiomyosarcoma. | Int J Gynecol Pathol | 2025 | 38847524 | PubTator, text mining | PubMed |
| H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric Gliomas. | bioRxiv | 2025 | 37398299 | PubTator, text mining | PubMed |
| Cancer-associated DAXX mutations reveal a critical role for ATRX localization in ALT suppression. | bioRxiv | 2024 | 39803578 | PubTator, text mining | PubMed |
| Correction: TSG101 depletion dysregulates mitochondria and PML NBs, triggering MAD2-overexpressing interphase cell death (MOID) through AIFM1-PML-DAXX pathway. | Cell Death Dis | 2024 | 39681555 | PubTator, text mining | PubMed |
| Progression of Low-Grade Neuroendocrine Tumors (NET) to High-Grade Neoplasms Harboring the NEC-Like Co-alteration of RB1 and TP53. | Endocr Pathol | 2024 | 39556303 | PubTator, text mining | PubMed |
| Diagnostic and prognostic biomarkers for pancreatic neuroendocrine neoplasms. | Pathologie (Heidelb) | 2024 | 39556246 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1616/papers?page=7